Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma

Clinical trial NCT04431089 · UNKNOWN

Trial details

NCT number: NCT04431089
Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma(FL)Marginal Zone Lymphoma(MZL)

Start date: 2020-05-09
Primary completion: 2021-04-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.